Skip to content

Ayurvedic treatment of Kushta by Patoladi kwath.

Randomized controlled clinical trial to evaluate the efficacy of Patoladi kwatha in the management of Eka Kushtha (Psoriasis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076725
Enrollment
92
Registered
2024-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Krushna Zod
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients Having Clinical Features Such As Mahavastu and Matsyashakalopama ,krushnaauna varna. Patients Showing Sign And Symptoms Of Psoriasis less than 1 year .

Exclusion criteria

Exclusion criteria: -Patients having sign and symptoms of eczema, lichen planus, actopic dermatitis, contact dermatitis, tinea corporis. -Patients with severe systemic diseases. -Patients with pregnancy and lactation. -Patients suffering from psoriatic arthritis.

Design outcomes

Primary

MeasureTime frame
MASTYASHAKAOLPAM (Scaling) will reduce. - MAHAVASTU (Degree of Involvement) will decrease. - KRUSHNAARUNA VARNA (Erythema) will reduce. Timepoint: 15th,30th,45th day

Secondary

MeasureTime frame
Size Of Patch will be measured by vernier caliper and it will decrease. PASI Score ( Psoriasis Area Severity Index) will decrease. Timepoint: 15th,30th,45th day

Countries

India

Contacts

Public ContactDr Shrikant Deshmukh

Chatrapati Shahu Maharaj Shikshan sanstha Ayurved Mahavidyalaya Kanchanwadi 431011

dr.shrikantgdeshmukh@gmail.com9921553999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026